Drug Profile
Thymocartin
Alternative Names: RGH 0206; Timocartin; TP4Latest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Gedeon Richter
- Developer Dr. Willmar Schwabe Group; Gedeon Richter
- Class Antirheumatics; Small molecules
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Fracture
Most Recent Events
- 05 Feb 2001 Discontinued-III for Fracture treatment in Belgium (Unknown route)
- 05 Feb 2001 Discontinued-III for Fracture treatment in Germany (Unknown route)
- 05 Feb 2001 Discontinued-III for Fracture treatment in Switzerland (Unknown route)